|
 |
 |
 |
Tumor-killing virus selectively targets diseased brain cells
February 20, 2008
New findings show that a specialized virus with the ability to reproduce its tumor-killing genes can selectively target tumors in the brains of mice and eliminate them. Healthy brain tissue remained virtually untouched, according to a Feb. 20 report in The Journal of Neuroscience. With more research, the technique could one day offer a novel way of treating brain cancer in humans. "Most importantly, this study finds that the virus can penetrate into the brain, where it even reaches cells that have migrated away from the main tumor," says Harald Sontheimer, PhD, of the University of Alabama at Birmingham, who was not affiliated with the study. "Assuming that the virus behaves similarly in humans, in the future, it may provide a novel and highly efficacious way to treat resistant tumors." The study is the culmination of six years of basic research into the fundamental processes of viruses and the cells they target, conducted by senior author Anthony van den Pol, PhD, and his team at Yale University School of Medicine. They set out to test the vesicular stomatis virus, which was selected for its ability to attack brain tumors and leave healthy tissue largely uninfected. Tumor cells from brain cancers commonly found both in people and in mice were implanted into immune-compromised mice, which then received an injection of the virus in the tail. By viewing fluorescent proteins embedded in both tumor and virus cells in the brains of living mice, van den Pol's team watched as the virus infected multiple sites in the brain, spreading across an entire tumor within three days, killing tumor cells in its wake. The virus did not target normal mouse tissue or non-cancerous human brain cells transplanted into the mouse brain, the team found. They speculated that, unlike those in healthy brain tissue, blood vessels within brain tumors may leak, allowing the virus to cross the usually impenetrable protective barrier around the brain. The virus was equally effective in destroying tissue from cancers that start in the breast or lung and spread to the brain-the two cancers most likely to metastasize to the brain-and targeted tumors at different sites throughout the body. Each year in the United States, more than 20,000 new cases of brain or nervous system cancers are diagnosed, according to the National Cancer Institute. Future research will focus on understanding potential safety risks, such as whether the virus could eventually infect normal brain cells, as well exploring potential changes to the virus that could mitigate such risk. "We have some ideas for making the virus safer in the human brain," says van den Pol. "This is important to prevent the virus from potentially infecting normal brain cells after it has targeted the brain tumor." Society for Neuroscience

|
Tumor Chapter 1
by Archaia Studios Press
Frank Armstrong has an inoperable brain tumor that’s killing him. In his final days, with his body, senses, and mind failing him, he’s going to do the one thing that he’s never been able to do before… save the girl. TUMOR is a dark Los Angeles noir from the Harvey Award nominated creators of the critically acclaimed ELK’S RUN.
|

|
Tumor
by Joshua Hale Fialkov (Author), Noel Tuazon (Illustrator)
From the Harvey Award-nominated creative team of Elk's Run comes Tumor, the critically acclaimed sensation that was the first graphic novel to debut exclusively on the Kindle E-Book Reader! Tumor is the story of Frank Armstrong, a man at the boot heel of the world, barely scraping up a living as a private investigator in modern day Los Angeles. He finally lands a big case, finding the missing daughter of a drug kingpin, just as he's taken by the symptoms of a late-stage brain tumor. Memories blend with reality, as the missing girl case starts to seep into the memory of his own missing wife from 20 years prior. Now, with days, maybe even hours, left to live, he must save this girl, while the one thing he's relied on all of his life fails him - his mind!
|

|
Tumor Chapter 2
by Archaia Studios Press
Frank Armstrong has an inoperable brain tumor that's killing him. In his final days, with his body, senses, and mind failing him, he's going to do the one thing that he's never been able to do before --save the girl. TUMOR is a dark Los Angeles noir from the Harvey Award nominated creators of the critically acclaimed ELK'S RUN.
|

|
Tumor Chapter 3
by Archaia Studios Press
Frank Armstrong has an inoperable brain tumor that's killing him. In his final days, with his body, senses, and mind failing him, he's going to do the one thing that he's never been able to do before -- save the girl.- TUMOR is a dark Los Angeles noir from the Harvey Award nominated creators of the critically acclaimed ELK'S RUN.
|

|
100 Questions & Answers About Brain Tumors, Second Edition
by Virginia Stark-Vance (Author)
Whether you¹re a newly diagnosed brain tumor patient, a survivor, or a friend or relative of either, this book offers help. The Second edition of 100 Questions & Answers About Brain Tumors continues the same doctor-patient collaboration, providing authoritative, practical answers to your questions regarding diagnostic testing, treatment options, clinical trials, and much more. Dr. Stark-Vance and M.L. Dubay discuss the latest brain tumor therapies, including the new anti-angiogenesis drugs and brain tumor vaccines. New illustrations throughout the book, from pathology to PET scans, help the reader gain a clear understanding of how brain tumors differ and why these differences are important in making treatment decisions. 100 Questions & Answers About Brain Tumors, Second Edition is an...
|

|
Living with a Brain Tumor: Dr. Peter Black's Guide to Taking Control of Your Treatment
by Peter Black (Author)
Each year, 100,000 people in the United States are diagnosed with a brain tumor. With his new book, Dr. Peter Black fills a gap in the lay readership, providing an accessible medical resource for adult patients and their families. Dr. Black, who has operated on more than 3,000 patients with brain tumors, is uniquely qualified to discuss both clinical treatment of and research into brain tumors. This invaluable resource tells patients everything they need to know to understand and address their diagnosis, in a four-part structure:
• “What is a Brain Tumor?" provides straightforward information about how brain tumors are diagnosed, the different types of tumors and how they develop, and where to go for treatment.
• “Coping with Shock” addresses the emotional...
|

|
Cancer In Dogs. Dog Cancer Information Including Best Dog Food, Vitamins, Supplements, Holistic Treatments for Dogs with Tumors and Raw Food Diet for Dogs.
Cancer In Dogs. Dog Cancer Information Including Best Dog Food, Vitamins, Supplements, Holistic Treatments for Dogs with Tumors and Raw Food Diet for Dogs.
Table of Content:
Understanding the Value of Natural Health for Your Dog
Historical References of the Diet of Wild Dogs
The Truth about What Dogs Are Meant To Eat
What Vets Say On Feeding a Raw Food Diet
Changes in Dog Care and Dog Health in the Past 80 Years
The Rise in Dog Cancer
Bone Cancer Types of Vaccines A Brief Description of Some of the Worst Dog Diseases Changes in Food Breeding and Care Veterinary Care
What to Do If You Think Your Dog Has Cancer Causes of...
|

|
Diagnostic Pathology: Soft Tissue Tumors: Published by Amirsys®
by Cyril Fisher (Author)
Designed as an easy-to-use and comprehensive reference for practicing pathologists, Diagnostic Pathology: Soft Tissue Tumors is a highly anticipated volume in the Diagnostic Pathology series offered by Amirsys. As readers have come to expect from Amirsys reference tools, Diagnostic Pathology: Soft Tissue Tumors is filled with over 2,500 superior medical images, including gross pathology, a wide range of pathology stains, and detailed medical illustrations. You'll also find essential information on staging and grading of soft tissue tumors, one of the most useful hallmarks of the series. More than 150 diagnoses are described in concise yet detailed bulleted text. This handsome volume is a veritable one-stop shop for the pathology of soft tissue tumors and their...
|

|
Medifocus Guidebook on: Carcinoid Tumor
by Medifocus.com Inc. (Author), Elliot Jacob PhD. (Editor)
The MediFocus Guidebook on Carcinoid Tumor is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Carcinoid Tumor, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Carcinoid Tumor, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts, institutions, and support...
|

|
Cutaneous Adnexal Tumors
by Dmitry V. Kazakov (Author), Phillip McKee (Author), Michal Michal (Author), Denise Kacerovska MD PhD (Author)
Adnexal tumors of the skin are complex, with confusing nomenclature. Many lesions show marked variation in histological appearance and there is considerable morphological overlap between different entities. These tumors are relatively rare, compared for example with melanocytic lesions, but still are part of everyday routine work for all histopathologists. Therefore, many general pathologists (the majority of whom are obliged to report dermatopathology specimens) are unfamiliar with the topic and even the experts have difficulties with the more challenging cases. Although the majority of adnexal tumors represent benign lesions, malignant counterparts do occur and these often represent a diagnostic pitfall. There are many inherited syndromes in which cutaneous adnexal tumors are a feature,...
|
|